Literature DB >> 11118369

Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection.

J M Lunetta1, J A Wiedeman.   

Abstract

Published studies have identified novel sense transcripts in latent human cytomegalovirus (HCMV) infection. These cytomegalovirus latency-associated transcripts (CLTs) have start sites upstream from the MIE gene productive start site (PSS). We evaluated the expression of the sense CLTs in an in vitro HCMV productive infection. Transcripts with initiation sites upstream from the PSS were detected in infected human fibroblasts using reverse transcription-polymerase chain reaction and 5' rapid amplification of cDNA ends (RACE) analysis. DNA sequencing of 5' RACE PCR products confirmed that the start sites were consistent with sense CLT expression. Furthermore, ribonuclease protection assay analysis showed that transcripts initiating at the latent start site-1 were most abundant at late times postinfection after transcription from the PSS had decreased. In addition, transcription consistent with sense CLT expression was identified in HCMV-infected dTHP-1 cells, monocyte-derived macrophages, and endothelial cells, as well as in clinical isolate-infected human fibroblasts. These findings clearly demonstrate the expression of sense CLTs during in vitro HCMV infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118369     DOI: 10.1006/viro.2000.0666

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Identification of human herpesvirus 6 latency-associated transcripts.

Authors:  Kazuhiro Kondo; Kazuya Shimada; Junji Sashihara; Keiko Tanaka-Taya; Koichi Yamanishi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6.

Authors:  Kazuhiro Kondo; Junji Sashihara; Kazuya Shimada; Masaya Takemoto; Kiyoko Amo; Hiromi Miyagawa; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 3.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

4.  Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions.

Authors:  Cui-Qing Yang; Ling-Feng Miao; Xing Pan; Cong-Cong Wu; Simon Rayner; Edward S Mocarski; Han-Qing Ye; Min-Hua Luo
Journal:  Arch Virol       Date:  2013-07-25       Impact factor: 2.574

Review 5.  Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.

Authors:  Barry Slobedman; Peter A Barry; Juliet V Spencer; Selmir Avdic; Allison Abendroth
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

6.  Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection.

Authors:  Matthew Reeves; David Woodhall; Teresa Compton; John Sinclair
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

7.  Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.

Authors:  P S Beisser; L Laurent; J L Virelizier; S Michelson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138.

Authors:  Siok-Keen Tey; Felicia Goodrum; Rajiv Khanna
Journal:  J Gen Virol       Date:  2010-04-07       Impact factor: 3.891

9.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.

Authors:  C Jenkins; W Garcia; M J Godwin; J V Spencer; J Lewis Stern; A Abendroth; B Slobedman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.